2018
DOI: 10.1002/ijc.31884
|View full text |Cite
|
Sign up to set email alerts
|

Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries

Abstract: Thyroid cancer incidence varies greatly between and within high‐income countries (HICs), and overdiagnosis likely plays a major role in these differences. Yet, little is known about the situation in low‐ and middle‐income countries (LMICs). We compare up‐to‐date thyroid cancer incidence and mortality at national and subnational levels. 599,851 thyroid cancer cases in subjects aged 20–74 reported in Cancer Incidence in Five Continents volume XI from 55 countries with at least 0.5 million population, aged 20–74 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
64
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 82 publications
(69 citation statements)
references
References 25 publications
4
64
0
1
Order By: Relevance
“…The high burden of thyroid cancer in Kerala could be due to overdiagnosis, 27 as was observed even in high-income and low- and middle-income countries. 28 AAR in Barshi rural is almost one third of urban PBCRs (males, 50.6 v 147.0; females, 61.0 v 146.8), and the increase in APC was less compared with urban PBCRs. This needs additional investigation.…”
Section: Discussionmentioning
confidence: 86%
“…The high burden of thyroid cancer in Kerala could be due to overdiagnosis, 27 as was observed even in high-income and low- and middle-income countries. 28 AAR in Barshi rural is almost one third of urban PBCRs (males, 50.6 v 147.0; females, 61.0 v 146.8), and the increase in APC was less compared with urban PBCRs. This needs additional investigation.…”
Section: Discussionmentioning
confidence: 86%
“…Over-detection practices, which become more prevalent as socioeconomic development grows, and under-diagnosis and under-reporting in countries with lower socioeconomic level, may also partly explain why incidence but not mortality rates increase together with socioeconomic development. [24][25][26][27][28] The rise in cancer incidence among Group B cancers across EdI is predominantly driven by lung cancer and explained by the earlier adoption and high prevalence of tobacco smoking in high EdI countries. 29 Lung, brain and pancreatic cancers still have limited early detection and treatment options, which may explain the similarity of the patterns between incidence and mortality rates.…”
Section: Group D: No Clear Association Of Incidence and Mortality Rmentioning
confidence: 99%
“…However, this does not mean that this is the direct cause of a lesion's malignancy (i.e., risk stratification in the thyroid nodule), but it is an indicator that the prognosis of malignancy is worse when the nodule is malignant. These risk factors are related to the population and the Human Development Index [26], [27].…”
Section: A Clinical Analysis Backgroundmentioning
confidence: 99%